[260] [261] Since the total number of microbial and viral cells in the human body (over 100 trillion) greatly outnumbers human cells (tens of trillions), [note 21] [260] [262] there is considerable potential for interactions between drugs and an individual's microbiome, including: drugs altering the composition of the human microbiome, drug metabolism by microbial enzymes modifying the drug's pharmacokinetic profile, and microbial drug metabolism affecting a drug's clinical efficacy and toxicity profile
[21] Studies have demonstrated that the presence of residual C-peptide in longstanding type-1 diabetes is associated with a lower risk for developing microvascular complications and a significant reduction in incidence of severe hypoglycaemia
ALC showed analgesic properties, by relieving acute and in chronic pain
It is also able to promote proper wound healing and eliminate toxic and oxidizing substances
While early data show improved persistence, only a minority of patients remain on therapy beyond two years
Use as directed by your healthcare professional.